Guangdong Zhongsheng Pharmaceutical Co., Ltd.
002317
Rang in Aktien
#4568
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical... Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the entire lifecycle of drug development, from research and development to manufacturing and commercialization. Its product portfolio encompasses both traditional Chinese medicines (TCM) and modern chemical pharmaceuticals. The company's robust research and development initiatives are directed towards creating solutions for a wide array of health conditions, specifically targeting ophthalmological, cardiovascular, cerebrovascular, respiratory, digestive, diabetic, oncological, and age-related degenerative diseases. Established in 1979, the company maintains its primary operations from its headquarters in Dongguan, China.
Aktienkurs
$3.89
Marktkapitalisierung
$3.30B
Veränderung (1 Tag)
-3.14%
Veränderung (1 Jahr)
43.11%
Land
CN
Handel Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Kategorie
Healthcare
Kursverlauf für Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Höchster Schlusskurs: $3.82 am 2026-10-01
Niedrigster Schlusskurs: $1.20 am 2009-12-01
Niedrigster Schlusskurs: $1.20 am 2009-12-01
Kursverlauf der Aktie von Guangdong Zhongsheng Pharmaceutical Co., Ltd. von 2009 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | 9.67% |
| 2025 | 69.73% |
| 2024 | -25.78% |
| 2023 | -48.47% |
| 2022 | 174.43% |
| 2021 | -13.29% |
| 2020 | 27.55% |
| 2019 | 16.87% |
| 2018 | -33.33% |
| 2017 | 5.53% |
| 2016 | -9.41% |
| 2015 | 26.15% |
| 2014 | -5.92% |
| 2013 | 29.15% |
| 2012 | 45.26% |
| 2011 | -24.39% |
| 2010 | -0.74% |
| 2009 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
